1986
DOI: 10.1136/pgmj.62.734.1081
|View full text |Cite
|
Sign up to set email alerts
|

Anticardiolipin antibodies—clinical associations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
68
1

Year Published

1990
1990
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 133 publications
(70 citation statements)
references
References 49 publications
(35 reference statements)
1
68
1
Order By: Relevance
“…1318 Two patients (cases 14 and 16) tested positive for anticardiolipin antibodies. An association between anticardiolipin antibodies and cerebral infarcts has been encountered with increasing frequency, 25 but only one case of cocaine-related stroke has been previously reported to have anticardiolipin antibodies. 26 We included case 17 in the series because of the clear temporal relation between the use of crack and the onset of the symptoms.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…1318 Two patients (cases 14 and 16) tested positive for anticardiolipin antibodies. An association between anticardiolipin antibodies and cerebral infarcts has been encountered with increasing frequency, 25 but only one case of cocaine-related stroke has been previously reported to have anticardiolipin antibodies. 26 We included case 17 in the series because of the clear temporal relation between the use of crack and the onset of the symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…2 -22 Strokes were initially described as isolated case reports 13 -4 ' 6 -7 or were incorporated in articles describing medical complications of cocaine. 25 As the frequency of cocaine use increased, cocaine-related strokes became part of larger series on neurologic complications of cocaine 14 or series on intracranial hemorrhages or ischemic infarcts, 13 ' 15161822 reflecting the continuous increase in their frequency.…”
mentioning
confidence: 99%
“…There is poor correlation between patients with thrombosis harboring ACLAs and those harboring LAs, and stronger, but still not concordant, correlation between patients with thrombosis with ACLAs and those with antibodies to B-2-GP-I or antibodies to phosphatidylserine, phosphatidylethanolamine, phosphatidylglycerol, phosphatidylinositol, annexin-V, and phosphatidylcholine. Although there are similarities, there are, at times, clinical, laboratory, and biochemical differences, particularly regarding prevalence, etiology, possible mechanisms of thrombosis, clinical presentations, diagnosis, and at times, management [4,5]. The ACLA-thrombosis antiphospholipid syndrome is much more common than the LA-thrombosis antiphospholipid syndrome, the ratio being approximately 5 to 1 [3,6,7].…”
Section: Antiphospholipid Syndromementioning
confidence: 99%
“…1,2 There are different subgroups of APLA. The most characterize include lupus anticoagulant (LA), anticardiolipin (ACA), anti-glycoprotein 1 based on detection methods.…”
Section: Introductionmentioning
confidence: 99%